Envestnet Asset Management
RXST icon

Envestnet Asset Management’s RxSight RXST Stock Holding History

Envestnet Asset Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,119
Closed -$210K – 4455
2024
Q4 		$210K Sell
6,119
-6,032
-50% -$272K ﹤0.01% 4075
2024
Q3 		$601K Buy
12,151
+1,277
+12% +$65.4K ﹤0.01% 3440
2024
Q2 		$654K Buy
10,874
+6,735
+163% +$385K ﹤0.01% 3301
2024
Q1 		$213K Buy
+4,139
New +$203K ﹤0.01% 3916

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Envestnet Asset Management's RXST Position: Q1 2025 in Review

Envestnet Asset Management sold out of RxSight (RXST) in Q1 2025, closing a stake of 6,119 shares — an estimated $210K sold.

Envestnet Asset Management first reported a position in RXST in Q1 2024 and held it in 4 quarters. The position peaked at $654K in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Envestnet Asset Management reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 6,119 RxSight shares in Q1 2025, an estimated $210K.
  • Envestnet Asset Management first reported a position in RxSight in Q1 2024 and held it in 4 quarters.
  • Envestnet Asset Management's RxSight position peaked at $654K in Q2 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Envestnet Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.